- Investing Ideas
- /
- Swiss Solid Balance Sheet and Fundamentals
Swiss Solid Balance Sheet and Fundamentals
UPDATED Sep 28, 2022
High return on equity, past performance and sound balance sheet.
18 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| PGHNPartners Group Holding | CHF810.00 | 0.5% | -44.8% | CHF21.1b | CHF1,255.67 | PE16.3x | E13.1% | 4.1% | Diversified Financials | ||
| LEHNLEM Holding | CHF1,560.00 | 2.0% | -28.1% | CHF1.8b | CHF1,826.67 | PE25.5x | E6.5% | 3.2% | Tech | ||
| BRKNBurkhalter Holding | CHF73.60 | 0.5% | 11.3% | CHF751.9m | CHF81.50 | PE29.2x | E26.5% | 5.2% | Capital Goods | ||
| VACNVAT Group | CHF210.00 | -1.2% | -43.3% | CHF6.3b | CHF307.00 | PE23.5x | E5.2% | 2.6% | Capital Goods | ||
| EMSNEMS-CHEMIE HOLDING | CHF618.50 | 1.4% | -30.0% | CHF14.5b | CHF902.29 | PE26x | E8.6% | 3.4% | Materials | ||
| SOONSonova Holding | CHF216.50 | -1.5% | -39.0% | CHF13.2b | CHF335.00 | PE20.4x | E10.5% | 2.0% | Healthcare | ||
| IFCNINFICON Holding | CHF661.00 | 1.1% | -39.7% | CHF1.6b | CHF883.63 | PE19.6x | E7.0% | 3.1% | Tech | ||
| CLTNCOLTENE Holding | CHF75.60 | -1.7% | -36.4% | CHF451.7m | CHF103.50 | PE17.6x | E10.0% | 4.4% | Healthcare | ||
| BEANBELIMO Holding | CHF359.50 | 10.6% | -27.2% | CHF4.4b | CHF385.71 | PE39x | E11.7% | 2.4% | Capital Goods | ||
| KNINKuehne + Nagel International | CHF209.40 | 1.7% | -34.4% | CHF25.2b | CHF277.00 | PE9x | E-24.9% | 4.8% | Transportation | ||
| COTNComet Holding | CHF149.40 | -6.2% | -53.9% | CHF1.2b | CHF247.20 | PE18.5x | E16.0% | 2.3% | Tech | ||
| STMNStraumann Holding | CHF89.84 | -1.2% | -46.6% | CHF14.3b | CHF141.61 | PE29.3x | E11.8% | 0.8% | Healthcare | ||
| BCHNBurckhardt Compression Holding | CHF366.50 | -3.6% | -2.8% | CHF1.2b | CHF508.00 | PE24.7x | E17.9% | 2.0% | Capital Goods | ||
| ABBNABB | CHF25.64 | 0.2% | -18.3% | CHF48.5b | CHF32.65 | PE11.4x | E9.0% | 3.1% | Capital Goods | ||
| NOVNNovartis | CHF74.82 | -0.3% | -2.6% | CHF163.3b | CHF88.74 | PE7.3x | E4.2% | 4.0% | Pharmaceuticals & Biotech | ||
| BOBNNBobst Group | CHF78.30 | -0.4% | -3.2% | CHF1.3b | CHF94.00 | PE11.9x | E4.4% | 2.6% | Capital Goods | ||
| MOLNMolecular Partners | CHF6.40 | 3.9% | -64.9% | CHF230.5m | CHF19.39 | PE1.9x | E-68.7% | n/a | Pharmaceuticals & Biotech | ||
| TXGNTX Group | CHF119.80 | -2.1% | -22.2% | CHF1.3b | CHF214.00 | PE1.6x | E-110.4% | 2.7% | Media |
Page 1 of 1